8/9/2022Analysis of Regulations for Approval of Digital Therapeutics in China

8/8/2022Hansoh and TiumBio Enter $164M Licensing Pact for TU2670 in China

8/8/2022AstraZeneca and Wuxi Biologics Tie Up to Make Preventive Covid-19 Jab ...

8/5/2022Recent Executive Moves

8/5/2022Bird's Eye View of Chinese Pharma Now: A Mixed Bag of Mostly Negative ...

8/2/2022China Slaps MAH System on Vaccine Manufacturing to Limit Newcomers (Ph...

7/29/2022Drug R&D and Approvals in China – June Update on YouTube (PharmCube)

7/29/2022Pricing and Market Access in China: How Medtechs Can Succeed

7/29/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines ICH ...

7/29/2022NHC and SATCM Issues Notice to Further Strengthen Drug Safety Manageme...

7/29/2022Recent Official and Executive Moves

7/29/2022Financial-related Company News in Brief (July 2022)

7/28/2022Cosmo and 3SBio Enter License Agreement for Winlevi in Greater China

7/28/2022June In-Licensing Deals in China Biotech Drop to A New Low (PharmaDJ)

7/26/2022Biotech fundraising in China Warms Up A Little in June (PharmaDJ)

7/26/2022Mobile Health Applications for Depression in China: A Systematic Revie...

7/26/2022NHSA and MOF Issues Notice to Further Implement BMI Inter-provincial M...

7/26/2022MSD and Kelun Enter Oncology Research Collaboration and License Agre...

7/26/2022Review of Chinese Hospital Drug Market in Q1/2022

7/22/2022AbbVie Terminates Early-stage Study of I-Mab's Antibody lemzoparlimab...

7/22/2022Two Chinese Biotechs Raise Millions for Shingles Vaccine Candidates to...

7/22/2022Novaremed Enters License Pact with NeuroFront for Non-opioid Neuropath...

7/21/2022WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...

7/21/2022A Practical Review of the New Supporting Regulations of China's Anti-M...

7/21/2022A Practical Review of the Amended Anti-Monopoly Law of China: Highligh...

7/21/2022Draft "Regulation on Prohibition for Abuse of IP Rights to Exclude or ...

7/20/2022China's Prospective Payment System: 3 Ways to Prepare

7/20/2022Official Data: Chinese Pharma Growth Slows in H1/2022

7/19/2022WuXi STA Opens a New Large Scale Continuous Manufacturing Plant

7/19/2022WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...

Page:67/361 Total number of articles:10802: [First][<<] [65] [66] [67] [68] [69] [>>] [End]